V-Square Quantitative Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$45.4K Sell
281
-350
-55% -$58.3K ﹤0.01% 594
2026
Q2
$120K Sell
631
-159
-20% -$29.9K 0.01% 532
2026
Q1
$156K Buy
+790
New +$152K 0.02% 523

Other funds holding AZN

V-Square Quantitative Management's AZN Position: Q3 2026 in Review

V-Square Quantitative Management reduced its AstraZeneca (AZN) stake by 55% in Q3 2026, selling an estimated $58.3K and leaving 281 shares worth $45.4K. The position accounts for ﹤0.01% of the portfolio, ranked #594.

V-Square Quantitative Management first reported a position in AZN in Q1 2026 and has held it in 3 quarters since. The position peaked at $156K in Q1 2026. 294 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • V-Square Quantitative Management held 281 shares of AstraZeneca worth $45.4K as of Q3 2026.
  • V-Square Quantitative Management sold 350 AstraZeneca shares in Q3 2026, an estimated $58.3K.
  • AstraZeneca made up ﹤0.01% of V-Square Quantitative Management's portfolio in Q3 2026, its #594 holding.
  • V-Square Quantitative Management first reported a position in AstraZeneca in Q1 2026 and has held it in 3 quarters since.
  • V-Square Quantitative Management's AstraZeneca position peaked at $156K in Q1 2026.
  • 294 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.